FDA Approved: MIRALAX — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental NDA for Miralax (polyethylene glycol 3350) filed by Bayer HealthCare LLC., updating the labeling for its approved use as a laxative.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

SUPPL AP for MIRALAX (POLYETHYLENE GLYCOL 3350)